The impact of the chronic disease assistance plan (CDAP) on the control of type 2 diabetes in Trinidad

Diabetes Research and Clinical Practice
Astral BobbKameel Mungrue

Abstract

(1) To measure the proportion of participants who used hypoglycaemic agents provided by CDAP only, for at least 6 months, and attained an HbA1c of <or=7% (a measure of glycaemic control) and (2) to determine the attitudes and practices of patients and pharmacist in this new programme. The attainment of a glycosylated haemoglobin (HbA1c) concentration of <or=7% in patients with type 2 diabetes mellitus was used as a measure of good glycaemic control. Consequently we measured the HbA1c in 208 subjects who satisfied the entry criteria. Two questionnaires were designed, pre-tested and administered to both patients and pharmacist in the programme to determine their attitudes and practices. Of the 208 eligible participants, 128 (61.5%) were well controlled, 94% of all participants were satisfied with CDAP and only 23.3% of participants experienced one or more minor side effect with the drugs used from CDAP. There were no significant differences between patients who were well controlled and poorly controlled with respect to gender, physical activity and diet. The study demonstrated that CDAP has impacted favorably on the control of type 2 diabetes mellitus in Trinidad, most participants were satisfied with the programme and there were...Continue Reading

References

Dec 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·M C GullifordD Mahabir
May 3, 2001·The New England Journal of Medicine·J TuomilehtoUNKNOWN Finnish Diabetes Prevention Study Group
Nov 28, 2002·Diabetes Care·UNKNOWN Diabetes Prevention Program (DPP) Research Group
Nov 25, 2003·Diabetes Care·Jaana LindströmUNKNOWN Finnish Diabetes Prevention Study Group
Jan 22, 2004·JAMA : the Journal of the American Medical Association·Sharon H SaydahCatherine C Cowie
Jan 27, 2005·Drugs·Andrew J Krentz, Clifford J Bailey
Dec 17, 2008·The American Economic Review·David CardNicole Maestas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.